NCT03606447View on ClinicalTrials.gov

A Study in Healthy Volunteers to Investigate How Much Test Medicine [14C]-Uproleselan is Taken up by the Body When Administered Directly Into the Vein (IV)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

September 13, 2018

Study Completion Date

September 13, 2018

Conditions

Healthy Subjects

Interventions

DRUG

Uproleselan

\[14C\]-Uproleselan

Trial Locations (1)

NG11 6JS

Quotient Sciences Limited, Ruddington

All Listed Sponsors

collaborator

Quotient Sciences

INDUSTRY

lead

GlycoMimetics Incorporated

INDUSTRY

NCT03606447 - A Study in Healthy Volunteers to Investigate How Much Test Medicine [14C]-Uproleselan is Taken up by the Body When Administered Directly Into the Vein (IV) | Biotech Hunter | Biotech Hunter